duloxetine 20 mg
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules are indicated for the treatment of: • Major depressive disorder in adults • Generalized anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults and pediatric patients 13 years of age and older • Chronic musculoskeletal pain in adults Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: • Major depressive disorder (MDD) in adults (1) • Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older (1) • Diabetic peripheral neuropathic pain (DPNP) in adults (1) • Fibromyalgia (FM) in adults and pediatric patients 13 years of age and older (1) • Chronic musculoskeletal pain in adults (1)
marksans pharma limited
CAPSULE GREEN RDY608 20mg
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Duloxetine Delayed-Release capsules USP, 20 mg: Opaque green/opaque green size '4' hard gelatin capsule filled with white to off-white-spherical enteric coated pellets and imprinted 'RDY608' on opaque green cap and '20 mg' on opaque green body with black ink. Bottles of 60 NDC 25000-608-06 Duloxetine Delayed-Release capsules USP, 30 mg: Opaque blue/opaque white size '3' hard gelatin capsule filled with white to off-white-spherical enteric coated pellets and imprinted 'RDY609' on opaque blue cap and '30 mg' on opaque white body with golden yellow ink. Bottles of 30 NDC 25000-609-03 Bottles of 90 NDC 25000-609-07 Duloxetine Delayed-Release capsules USP, 60 mg: Opaque blue/opaque green size '1' hard gelatin capsule filled with white to off-white spherical enteric coated pellets and imprinted 'RDY610' on opaque blue cap and '60 mg' on opaque green body with white ink. Bottles of 30 NDC 25000-610-03 Bottles of 90 NDC 25000-610-07 16.2 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
More pills like CAPSULE RDY608 20mg